Advertisement

Topics

New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

08:10 EDT 26 Mar 2019 | Xconomy

Aldeyra Therapeutics has disclosed positive results from the first of multiple Phase 3 studies of a new type of inflammation-fighting medicine the Lexington, MA, company has been testing in a variety of conditions. The study Aldeyra (NASDAQ: ALDX) reports on this morning is a Phase 3 trial called “Alleviate,” which tested its drug reproxalap against […]

Original Article: New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

NEXT ARTICLE

More From BioPortfolio on "New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...